NeuroPred
Coralville
About NeuroPred
NeuroPred is a pioneering company in precision health focused on revolutionizing stroke care through AI-driven personalized prognosis. It leverages artificial intelligence combined with clinical MRI data to deliver detailed risk prognoses, enabling clinicians and patients to access individualized insights for better-informed treatment decisions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $2.5K
- Last round: Grant (Nov 2025)
- Website: neuropred.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI)
Canonical: https://fsome.com/organization/neuropred-190920 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.